Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
OtherShort Communication

COMPARATIVE METABOLISM OF THE TOBACCO-SPECIFIC NITROSAMINES 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE AND 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL BY RAT CYTOCHROME P450 2A3 AND HUMAN CYTOCHROME P450 2A13

John R. Jalas, Xinxin Ding and Sharon E. Murphy
Drug Metabolism and Disposition October 2003, 31 (10) 1199-1202; DOI: https://doi.org/10.1124/dmd.31.10.1199
John R. Jalas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinxin Ding
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon E. Murphy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 31 no. 10 1199-1202
DOI 
https://doi.org/10.1124/dmd.31.10.1199
PubMed 
12975327

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received May 27, 2003
  • Accepted June 23, 2003
  • Published online September 15, 2003.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. John R. Jalas,
  2. Xinxin Ding and
  3. Sharon E. Murphy
  1. Department of Chemistry (J.R.J.) and Cancer Center (J.R.J., S.E.M.), University of Minnesota, Minneapolis, Minnesota; and Wadsworth Center, New York State Department of Health and School of Public Health, State University of New York at Albany Albany New York (X.D.)
  1. Address correspondence to:
    Sharon E. Murphy, Cancer Center, University of Minnesota, MMC 806, 420 Delaware St. SE, Minneapolis, MN 55455. E-mail: murph062{at}umn.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to May 2023

AbstractFullPdf
Aug 20170188
Sep 20170173
Oct 20171284
Nov 20170315
Dec 20170152
Jan 20181102
Feb 20182224
Mar 20183305
Apr 20184314
May 20180231
Jun 20181213
Jul 20181236
Aug 20180892
Sep 20180152
Oct 20180130
Nov 20180165
Dec 20182955
Jan 2019811
Feb 2019532
Mar 2019800
Apr 20191600
May 20191000
Jun 20191312
Jul 20191300
Aug 20192000
Oct 20191400
Nov 20191310
Dec 20191730
Jan 20201021
Feb 20201900
Mar 20202622
May 2020710
Jun 2020700
Jul 2020912
Aug 2020621
Sep 20201111
Oct 2020500
Nov 2020800
Dec 20201431
Jan 20211050
Feb 202111100
Mar 20211210
Apr 20211910
May 20213440
Jun 20212450
Jul 20212231
Aug 20212260
Sep 20211530
Oct 20213031
Nov 20212010
Dec 20212321
Jan 20221921
Feb 20221421
Mar 20221321
Apr 2022942
May 2022821
Jun 20221521
Jul 20221610
Aug 20221010
Sep 20222110
Oct 20221551
Nov 20221610
Dec 20222210
Jan 20231310
Feb 2023950
Mar 20236210
Apr 2023920
May 20231810

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 31 (10)
Drug Metabolism and Disposition
Vol. 31, Issue 10
1 Oct 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
COMPARATIVE METABOLISM OF THE TOBACCO-SPECIFIC NITROSAMINES 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE AND 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL BY RAT CYTOCHROME P450 2A3 AND HUMAN CYTOCHROME P450 2A13
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherShort Communication

COMPARATIVE METABOLISM OF THE TOBACCO-SPECIFIC NITROSAMINES 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE AND 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL BY RAT CYTOCHROME P450 2A3 AND HUMAN CYTOCHROME P450 2A13

John R. Jalas, Xinxin Ding and Sharon E. Murphy
Drug Metabolism and Disposition October 1, 2003, 31 (10) 1199-1202; DOI: https://doi.org/10.1124/dmd.31.10.1199

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherShort Communication

COMPARATIVE METABOLISM OF THE TOBACCO-SPECIFIC NITROSAMINES 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE AND 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL BY RAT CYTOCHROME P450 2A3 AND HUMAN CYTOCHROME P450 2A13

John R. Jalas, Xinxin Ding and Sharon E. Murphy
Drug Metabolism and Disposition October 1, 2003, 31 (10) 1199-1202; DOI: https://doi.org/10.1124/dmd.31.10.1199
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Preincubation Effects on Inhibition of OCT1 by CsA
  • Carbamazepine Metabolite and Hypersensitivity Reactions
  • SULT4A1 Preserves Mitochondrial Function
Show more Short Communications

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics